PFE vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Palantir Technologies Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
VS
Palantir Technologies Inc. ยท Technology
$189.67
+2.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
PFE |
PLTR |
| Current Price |
$27.64 |
$189.67 |
| Fair Value Estimate |
$30.94 |
$194.30 |
| Upside to Fair Value |
+12.0%
|
+2.4%
|
| Market Cap |
$157.5B |
$435.5B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
17.4x
|
139.9x
|
| Price / Sales |
2.5x
|
70.7x
|
| Price / FCF |
14.3x
|
135.3x
|
| Revenue Growth YoY |
+2.6%
|
+92.8%
|
| Gross Margin |
71.3%
|
84.8%
|
| Operating Margin |
25.1%
|
42.8%
|
| Return on Equity |
4.9%
|
37.5%
|
| Dividend Yield |
6.22% |
0% |
| FCF Yield |
6.97%
|
0.74%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โฆ
Palantir Technologies Inc. is a software infrastructure company founded in 2003 and headquartered in Denver that builds and deploys Gotham for intelligence and defense workflows, Foundry as a central data operating system for enterprises, Apollo for software delivery across environments, and its Artificial Intelligence Platform (AIP) for unified access to open-source, self-hosted, and commercial โฆ
Accumulation Zones
| Metric |
PFE |
PLTR |
| Zone Low |
$23.21 |
$145.73 |
| Zone High |
$26.30 |
$165.16 |
| In Buy Zone? |
No
|
No
|